Viewing StudyNCT00039130



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00039130
Status: COMPLETED
Last Update Posted: 2023-08-21
First Post: 2002-06-06

Brief Title: Rituximab Chemotherapy and Filgrastim in Treating Patients With Burkitts Lymphoma or Burkitts Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Organization Data

Organization: Alliance for Clinical Trials in Oncology
Class: OTHER
Study ID: CALGB-10002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Alliance for Clinical Trials in Oncology
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH